Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2502275289;75290;75291 chr2:178571068;178571067;178571066chr2:179435795;179435794;179435793
N2AB2338170366;70367;70368 chr2:178571068;178571067;178571066chr2:179435795;179435794;179435793
N2A2245467585;67586;67587 chr2:178571068;178571067;178571066chr2:179435795;179435794;179435793
N2B1595748094;48095;48096 chr2:178571068;178571067;178571066chr2:179435795;179435794;179435793
Novex-11608248469;48470;48471 chr2:178571068;178571067;178571066chr2:179435795;179435794;179435793
Novex-21614948670;48671;48672 chr2:178571068;178571067;178571066chr2:179435795;179435794;179435793
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: TCT
  • RefSeq wild type template codon: AGA
  • Domain: Fn3-70
  • Domain position: 17
  • Structural Position: 19
  • Q(SASA): 0.141
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/Y rs374537008 -0.561 0.995 N 0.742 0.42 None gnomAD-2.1.1 4.03E-06 None None None None N None 6.46E-05 0 None 0 0 None 0 None 0 0 0
S/Y rs374537008 -0.561 0.995 N 0.742 0.42 None gnomAD-4.0.0 1.20033E-06 None None None None N None 6.33473E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.0844 likely_benign 0.0849 benign -0.472 Destabilizing 0.78 D 0.535 neutral N 0.488154183 None None N
S/C 0.0948 likely_benign 0.0959 benign -1.034 Destabilizing 0.999 D 0.698 prob.neutral N 0.500057147 None None N
S/D 0.5509 ambiguous 0.5678 pathogenic -2.04 Highly Destabilizing 0.851 D 0.573 neutral None None None None N
S/E 0.6014 likely_pathogenic 0.616 pathogenic -1.981 Destabilizing 0.851 D 0.55 neutral None None None None N
S/F 0.2262 likely_benign 0.2273 benign -0.906 Destabilizing 0.995 D 0.746 deleterious N 0.500791163 None None N
S/G 0.122 likely_benign 0.1163 benign -0.683 Destabilizing 0.851 D 0.545 neutral None None None None N
S/H 0.2679 likely_benign 0.2789 benign -1.181 Destabilizing 0.988 D 0.721 prob.delet. None None None None N
S/I 0.2451 likely_benign 0.2478 benign -0.012 Destabilizing 0.988 D 0.763 deleterious None None None None N
S/K 0.5308 ambiguous 0.564 pathogenic -0.587 Destabilizing 0.132 N 0.353 neutral None None None None N
S/L 0.12 likely_benign 0.1228 benign -0.012 Destabilizing 0.959 D 0.687 prob.neutral None None None None N
S/M 0.1838 likely_benign 0.1913 benign 0.029 Stabilizing 0.999 D 0.707 prob.neutral None None None None N
S/N 0.1542 likely_benign 0.1595 benign -1.099 Destabilizing 0.034 N 0.351 neutral None None None None N
S/P 0.9808 likely_pathogenic 0.9839 pathogenic -0.135 Destabilizing 0.995 D 0.731 prob.delet. D 0.547368473 None None N
S/Q 0.4691 ambiguous 0.4932 ambiguous -1.295 Destabilizing 0.507 D 0.365 neutral None None None None N
S/R 0.4539 ambiguous 0.48 ambiguous -0.47 Destabilizing 0.851 D 0.68 prob.neutral None None None None N
S/T 0.0732 likely_benign 0.0777 benign -0.779 Destabilizing 0.896 D 0.555 neutral D 0.526066496 None None N
S/V 0.2311 likely_benign 0.2382 benign -0.135 Destabilizing 0.988 D 0.73 prob.delet. None None None None N
S/W 0.4148 ambiguous 0.4087 ambiguous -1.099 Destabilizing 0.999 D 0.783 deleterious None None None None N
S/Y 0.2038 likely_benign 0.1975 benign -0.639 Destabilizing 0.995 D 0.742 deleterious N 0.495498017 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.